Ozempic vs. Wegovy: What's the Difference?

Same molecule, different doses and indications. Here's what you actually need to know about semaglutide before starting treatment.

They're the Same Drug — at Different Doses

Ozempic and Wegovy both contain semaglutide — a once-weekly injectable medication that mimics the GLP-1 hormone. The key difference is dosage and FDA-approved indication:

• Ozempic is approved for type 2 diabetes at doses up to 2 mg weekly.
• Wegovy is approved for chronic weight management at a maximum dose of 2.4 mg weekly.

Both work the same way: they slow stomach emptying, reduce appetite, and stimulate insulin release in response to meals. The higher dose in Wegovy simply produces greater weight loss on average.

Ozempic: Diabetes First

Ozempic (semaglutide 0.5 mg, 1 mg, or 2 mg weekly) was FDA approved in 2017 for type 2 diabetes. In the landmark SUSTAIN clinical trials, it reduced A1c by 1–1.5 percentage points and reduced the risk of major cardiovascular events (heart attack, stroke) in patients with established cardiovascular disease.

Weight loss of 5–10% is common on Ozempic, which is why many patients and physicians discuss it for obesity as well — but this is an off-label use. Your insurance may not cover it for that purpose.

Wegovy: Weight Loss Approved

Wegovy (semaglutide 2.4 mg weekly) was FDA approved in 2021 specifically for chronic weight management in adults with:

• BMI ≥ 30 (obesity), or
• BMI ≥ 27 (overweight) with at least one weight-related condition (high blood pressure, type 2 diabetes, high cholesterol, sleep apnea, etc.)

In the STEP clinical trials, patients on Wegovy lost an average of 15% of their body weight over 68 weeks — far exceeding any previous weight loss medication. For a 250-lb person, that's roughly 37 pounds.

In 2024, the FDA also approved Wegovy for reducing cardiovascular risk (heart attack and stroke) in people with obesity and established cardiovascular disease — a landmark expansion of its indication.

Rybelsus: The Pill Form

For patients who prefer not to inject, Rybelsus (oral semaglutide) is an option for type 2 diabetes. It must be taken first thing in the morning on an empty stomach with no more than 4 oz of plain water, waiting 30 minutes before eating or drinking anything else. Absorption is lower than the injectable form, so the doses are higher (3 mg, 7 mg, or 14 mg daily).

Side Effects and What to Expect

The most common side effects of semaglutide are gastrointestinal and tend to be worst when starting or increasing the dose:

• Nausea — most common, especially in the first weeks. Usually improves with time.
• Vomiting — less common, more likely at higher doses.
• Constipation — common, especially compared to older GLP-1s.
• Diarrhea — some patients experience this instead of constipation.
• Decreased appetite — usually a desired effect for weight management.

Eating smaller meals, avoiding fatty or spicy foods, and staying well hydrated can help manage early side effects. Most people find side effects improve significantly after the first 4–8 weeks.

What Happens If You Stop?

This is one of the most important things to understand about semaglutide: the effects are not permanent. Most patients regain a significant portion of lost weight within 1–2 years of stopping Wegovy. This is not a failure of willpower — it reflects the biology of obesity as a chronic condition, similar to how blood pressure returns when you stop a blood pressure medication.

For this reason, most guidelines now frame GLP-1 therapy as a long-term or indefinite treatment for many patients with obesity, not a short-term fix.

Common Questions

Can I use Ozempic for weight loss even if I don't have diabetes?
Technically your doctor can prescribe it off-label, but insurance typically won't cover it for that purpose. Wegovy is the appropriate on-label choice for weight loss in people without diabetes.

Is semaglutide the same as compounded semaglutide?
No. During the shortage period, compounded versions were permitted. The FDA has declared the shortage over, meaning compounded semaglutide is no longer legally authorized for most patients. Be cautious with any product that isn't an FDA-approved brand-name medication.

Do I need to take it forever?
For weight management, most evidence suggests long-term use is needed to maintain results. Your endocrinologist will help you weigh the benefits, risks, and logistics of ongoing treatment.

What about muscle loss?
Rapid weight loss from any cause, including GLP-1 medications, can involve some muscle loss. Exercise — especially resistance training — is critically important to preserve muscle while on these medications. See our article on muscle loss and exercise during GLP-1 therapy.